Compugen (NASDAQ:CGEN) just reported results for the fourth quarter of 2023. Compugen reported earnings per share of 11 cents. This was below the analyst estimate for EPS of 23 cents. The company ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

Shares of CGEN stock opened at $2.00 on Monday. Compugen has a 12 month low of $1.35 and a 12 month high of $3.03. The stock has a market cap of $178.47 million, a P/E ratio of 100.00 and a beta ...

This suggests that analysts have very recently bumped up their estimates for CGEN, giving the stock a Zacks Earnings ESP of +451.63% heading into earnings season. Compugen Ltd. price-eps-surprise ...

Reveal insider sentiment with alternative data that tracks buy and sell trades made by top managers and company directors.

Compugen Ltd. (NASDAQ:CGEN – Get Free Report) shares passed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $1.74 and traded as ...

Compugen (CGEN) announced that the first patient was dosed in a Phase 1 clinical trial with COM503, a potential first-in-class antibody against IL-18 binding protein licensed by Compugen to Gilead.

Real time quote data is not available at this time. Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day.

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.